{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:35:22Z","timestamp":1794998122275,"version":"4.9.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Multiple pharmacological interventions have been studied for managing eosinophilic esophagitis (EoE). We performed a comprehensive systematic review and network meta-analysis of all available randomized controlled trials (RCT) to assess the efficacy and safety of these interventions in EoE in adults and children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We performed a comprehensive review of Embase, PubMed, MEDLINE OVID, Cochrane CENTRAL, and Web of Science through May 10, 2023. We performed frequentist approach network meta-analysis using random effects model. We calculated the odds ratio (OR) with 95% CI for dichotomous outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Our search yielded 25 RCTs with 25 discrete interventions and 2067 patients. Compared with placebo, the following interventions improved histology (using study definitions) in decreasing order on ranking: orodispersible budesonide (ODB) low dose, ODB high dose, oral viscous budesonide (OVB) high dose, fluticasone tablet 1.5\u00a0mg twice daily, fluticasone 3\u00a0mg twice daily, esomeprazole, dupilumab every 2 weeks, dupilumab weekly, OVB medium dose, fluticasone 3\u00a0mg daily, cendakimab 180\u00a0mg, prednisone, swallowed fluticasone, fluticasone tablet 1.5\u00a0mg daily, OVB low dose, reslizumab 3\u00a0mg\/kg, reslizumab 1\u00a0mg\/kg, and reslizumab 2\u00a0mg\/kg.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Network meta-analysis demonstrates histological efficacy of multiple medications for EoE. Because of the heterogeneity and large effect size, we recommend more trials comparing pharmacotherapeutic interventions with each other and placebo. An important limitation of this study is absence of clinical efficacy data due to insufficient data. Other limitations include heterogeneity of operator, population, and outcome analysis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcg.0000000000002017","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:00:48Z","timestamp":1714748448000},"page":"433-442","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Histological Outcomes of Pharmacological Interventions in Eosinophilic Esophagitis for Adults and Children"],"prefix":"10.1097","volume":"59","author":[{"given":"Muhammad","family":"Aziz","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Haghbin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH"},{"name":"Division of Gastroenterology, Ascension Providence Southfield, Southfield, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh K.","family":"Gangwani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawish","family":"Fatima","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Sohail","sequence":"additional","affiliation":[{"name":"Department of General Surgery, New York University Langone Health, Long Island, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassam","family":"Ali","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, East Carolina University, Greenville, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria A.","family":"Alyousif","sequence":"additional","affiliation":[{"name":"Respiratory Care, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushyant S.","family":"Dahiya","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Kansas, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Lee-Smith","sequence":"additional","affiliation":[{"name":"University of Toledo Libraries, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizullah","family":"Beran","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Kamal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nawras","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Toledo, Toledo, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5]]},"reference":[{"key":"R1-20250407","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.15231","article-title":"Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"49","author":"Navarro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R2-20250407","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic esophagitis: a review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"key":"R3-20250407","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.cgh.2020.01.024","article-title":"Efficacy of therapy for eosinophilic esophagitis in real-world practice","volume":"18","author":"Laserna-Mendieta","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20250407","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"R5-20250407","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.anai.2022.10.004","article-title":"Current state of biologics in treating eosinophilic esophagitis","volume":"130","author":"Nhu","year":"2023","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"R6-20250407","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"R7-20250407","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"R8-20250407","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R9-20250407","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R10-20250407","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R11-20250407","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cgh.2012.03.018","article-title":"Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-20250407","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa\u2019ad","year":"2011","journal-title":"Gastroenterology"},{"key":"R13-20250407","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.gastro.2014.04.019","article-title":"Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis","volume":"147","author":"Butz","year":"2014","journal-title":"Gastroenterology"},{"key":"R14-20250407","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.gastro.2012.04.049","article-title":"Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis","volume":"143","author":"Dellon","year":"2012","journal-title":"Gastroenterology"},{"key":"R15-20250407","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","article-title":"Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis","volume":"152","author":"Dellon","year":"2017","journal-title":"Gastroenterology"},{"key":"R16-20250407","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"R17-20250407","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N Engl J Med"},{"key":"R18-20250407","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cgh.2022.02.013","article-title":"Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R19-20250407","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2010.05.001","article-title":"Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial","volume":"139","author":"Dohil","year":"2010","journal-title":"Gastroenterology"},{"key":"R20-20250407","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cgh.2014.05.021","article-title":"Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis","volume":"13","author":"Gupta","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-20250407","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"R22-20250407","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/apt.15670","article-title":"Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis","volume":"51","author":"Hirano","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-20250407","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"R24-20250407","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cgh.2021.04.022","article-title":"Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial","volume":"20","author":"Hirano","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250407","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","article-title":"A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis","volume":"131","author":"Konikoff","year":"2006","journal-title":"Gastroenterology"},{"key":"R26-20250407","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"R27-20250407","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gutjnl-2014-308815","article-title":"A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis","volume":"65","author":"Miehlke","year":"2016","journal-title":"Gut"},{"key":"R28-20250407","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ajg.2012.443","article-title":"Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia","volume":"108","author":"Moawad","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R29-20250407","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10620-009-0859-4","article-title":"Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis","volume":"55","author":"Peterson","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R30-20250407","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R31-20250407","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","article-title":"Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children","volume":"6","author":"Schaefer","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R32-20250407","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R33-20250407","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"R34-20250407","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2010.07.048","article-title":"Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis","volume":"139","author":"Straumann","year":"2010","journal-title":"Gastroenterology"},{"key":"R35-20250407","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2022.10.026","article-title":"Breaking down the complex pathophysiology of eosinophilic esophagitis","volume":"130","author":"Underwood","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R36-20250407","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/gastroent13030023","article-title":"Exploring treatment options for eosinophilic esophagitis","volume":"13","author":"Strossman","year":"2022","journal-title":"Gastroenterology Insights"},{"key":"R37-20250407","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.giec.2017.08.001","article-title":"Latest insights on the relationship between symptoms and biologic findings in adults with eosinophilic esophagitis","volume":"28","author":"Safroneeva","year":"2018","journal-title":"Gastrointest endosc clin N Am"},{"key":"R38-20250407","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gutjnl-2023-329864","article-title":"Toning down the role of eosinophils in eosinophilic oesophagitis","volume":"73","author":"Rossi","year":"2024","journal-title":"Gut"},{"key":"R39-20250407","doi-asserted-by":"crossref","first-page":"e12146","DOI":"10.1002\/clt2.12146","article-title":"Primary eosinophilic gastrointestinal disorders and allergy: clinical and therapeutic implications","volume":"12","author":"Rossi","year":"2022","journal-title":"Clinic Transl Allergy"},{"key":"R40-20250407","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/gutjnl-2023-329873","article-title":"Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis","volume":"72","author":"Visaggi","year":"2023","journal-title":"Gut"},{"key":"R41-20250407","doi-asserted-by":"crossref","first-page":"1756284820980860","DOI":"10.1177\/1756284820980860","article-title":"Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults","volume":"14","author":"Visaggi","year":"2021","journal-title":"Therap adv gastroenterol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T19:54:14Z","timestamp":1744055654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002017"}},"subtitle":["A Network Meta-analysis of Randomized Controlled Trials"],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002017","relation":{},"ISSN":["1539-2031"],"issn-type":[{"value":"1539-2031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"2023-12-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}